Pfizer plans to apply for approval of its RSV vaccine by year’s end, in hopes a vaccine could be available before next year’s respiratory-illness season.
Category: Washington Post
A new tool to help prevent malaria shows promise: Antibody drugs
A trial in Mali showed for the first time that an antibody drug can be used to prevent malaria, a disease that kills more than half-a-million people each year.
Parasite cleanses are ‘modern snake oil.’ Experts explain why.
Scientists argue it’s highly unlikely that you have intestinal parasites. But even if you do, a home remedy won’t do much, they say.
These comics show: There is no typical abortion story
Political narratives can flatten the reality of abortion. In these four comics, we depicted the complexities.
One in 10 older adults in U.S. has dementia, research suggests
The dementia rate was higher for older adults who identify as Black or African American than for their counterparts.
Covid uses our proteins against us. A new strategy seeks to block that.
Scientists are exploring treatments that would remain effective regardless of how the virus evolves.
Is a hiatal hernia causing your GI symptoms? What to look for.
The good news is that diet and lifestyle changes can go a long way toward treating the common medical problem.
Can stress spread like a virus? What animals tell us.
What they learn could inform animal treatment and shed light on the nature of stress.
A VA biobank is the largest source of genetic data on Black Americans
The Million Veteran Program holds data on over 150,000 Black Americans — more than any other source.
So far, this flu season is more severe than it has been in 13 years
The flu has hospitalized a record number of people this season, underscoring the potential for a perilous winter of respiratory viruses with covid-19 and RSV.
